Drug Price Increases: Ozempic, Mounjaro and More Than 700 Medications

Drug price increases affected more than 700 medications at the beginning of 2024, including widely used medicines such as Ozempic, Mounjaro, Enbrel, OxyContin, Plavix, and Wellbutrin.

The average price increase was approximately 4.5%, according to the analysis reported at the time. Although prescription drug prices continued to rise, the increase was slightly lower than the average annual increase of about 5% recorded during the previous five years.

Some of the most closely watched increases involved Ozempic and Mounjaro, two medications in the glucagon-like peptide-1 (GLP-1) drug class.

Drug Price Increases in 2024

Prescription drug prices can change throughout the year, but January has historically been an important period for pharmaceutical price adjustments.

An analysis cited in the original report found that more than 60% of brand-name drug list price increases occurring since 2018 had been implemented in January.

The analysis focused on wholesale acquisition cost (WAC), which is the manufacturer's list price for a drug sold to wholesalers before discounts, rebates, and other adjustments.

This distinction is important because the list price is not necessarily the amount a patient ultimately pays at the pharmacy.

Why Did Drug Prices Increase?

Several factors can influence prescription drug pricing.

Pharmaceutical companies may consider factors such as:

• Inflation

• Market conditions

• Healthcare system changes

• Manufacturing costs

• Distribution costs

• Reimbursement arrangements

• Competition within a drug market

Drug pricing in the United States is also complicated by the involvement of manufacturers, wholesalers, pharmacies, insurers, pharmacy benefit managers, and other healthcare organizations.

As a result, an increase in a manufacturer's list price does not necessarily translate into the same percentage increase in a patient's out-of-pocket cost.

Ozempic Price Increase

One of the notable drug price increases involved Ozempic, a prescription medication manufactured by Novo Nordisk.

According to the January 2024 report, the list price of Ozempic increased by approximately 3.5%, reaching about $984.29 for a month's supply.

Ozempic contains semaglutide and is approved for the treatment of type 2 diabetes in appropriate patients.

The medication belongs to a class known as GLP-1 receptor agonists.

These medicines can improve blood glucose control and may also promote weight loss. The weight-loss effects of GLP-1 medications have contributed to increased public interest and demand for drugs in this class.

It is important to distinguish between an approved indication and a medication's other effects. Ozempic is approved for specific medical uses, while semaglutide is also marketed under other brand names for different indications.

Mounjaro Price Increase

Mounjaro was another high-profile medication affected by the reported price increases.

Manufactured by Eli Lilly, Mounjaro contains tirzepatide and is used to improve blood sugar control in adults with type 2 diabetes, alongside diet and exercise.

According to the report, Mounjaro's price increased by approximately 4.5%, bringing the reported list price to around $1,000 for a month's supply.

Tirzepatide has also attracted significant attention because of its effects on body weight. The high demand for medications with weight-loss benefits has contributed to considerable public and commercial interest in this class of medicines.

Other Medications With Price Increases

Ozempic and Mounjaro were not the only medications affected.

The analysis cited in the original report identified price increases for several other widely used prescription drugs.

Examples included:

These figures refer to the reported changes in list prices and should not be interpreted as the exact amount every patient paid.

The actual cost can vary considerably depending on insurance coverage, discounts, rebates, deductibles, copay arrangements, and the patient's source of medication.

Do List Price Increases Affect What Patients Pay?

Not necessarily.

This is one of the most important points to understand when discussing prescription drug prices.

The analysis was based on wholesale acquisition cost, rather than the final amount paid by an individual patient.

A patient's out-of-pocket cost may be affected by:

• Health insurance coverage

• Deductibles

• Copayments

• Coinsurance

• Manufacturer savings programs

• Pharmacy discounts

• Rebates

• Formularies

• Patient assistance programs

Therefore, a 5% increase in a manufacturer's list price does not automatically mean that every patient will experience a 5% increase at the pharmacy counter.

Novo Nordisk also emphasized this distinction when discussing its medicines, noting that list prices do not necessarily represent what most insured patients pay out of pocket.

Were Any Drug Prices Reduced?

Yes.

While drug price increases received considerable attention, the January 2024 analysis also identified approximately two dozen medications whose prices decreased significantly.

Some of the price reductions involved insulin products.

Other medicines reported to have experienced price decreases included:

The reported changes demonstrate that prescription drug pricing does not move in only one direction. While many medications experienced price increases, some manufacturers also reduced the list prices of certain products.

Insulin Prices Declined

Insulin pricing has received significant attention in the United States because of the financial burden that insulin costs can place on people who depend on the medication.

The 2024 report highlighted significant reductions in the prices of certain insulin products.

Novo Nordisk's insulin products marketed under the Novolog brand were reported to have a list-price reduction of approximately 75% compared with the previous year.

These reductions followed increased attention to insulin affordability and policy changes affecting the amount some patients pay for insulin.

For Medicare beneficiaries, a federal policy established a $35 monthly copay limit for covered insulin products, helping reduce out-of-pocket costs for eligible patients.

The broader insulin pricing landscape is complex, however, and patients' actual costs depend on their insurance coverage and the specific insulin product they use.

What Drug Price Changes Mean for Patients

Changes in prescription drug prices can have important consequences for patients.

Even when insurance covers part of the cost, higher prices can contribute to increased healthcare spending through deductibles, coinsurance, premiums, or other mechanisms.

For patients who do not have adequate insurance coverage, the impact can be even more significant.

High medication costs may contribute to difficult decisions about healthcare spending and, in some cases, may affect whether patients can consistently obtain their medicines.

This is particularly important for people who rely on long-term treatment for chronic conditions such as diabetes, cardiovascular disease, autoimmune diseases, depression, and respiratory conditions.

What can patients do?

Patients who are concerned about medication costs can speak with a pharmacist, prescriber, or insurer about possible options.

Depending on the medication and individual circumstances, alternatives may include:

• Generic versions

• Therapeutic alternatives

• Different formulations

• Manufacturer assistance programs

• Insurance formulary alternatives

• Pharmacy discount programs

• Patient assistance programs

Patients should not stop or change a prescribed medication solely because of its price without discussing the situation with an appropriate healthcare professional.

Why Drug Pricing Remains a Major Healthcare Issue

The continuing discussion around prescription drug prices highlights a broader issue in healthcare: access to medicines depends not only on whether an effective treatment exists, but also on whether patients can afford to obtain it.

For pharmaceutical companies, pricing decisions may reflect complex commercial and economic considerations.

For insurers and healthcare organizations, drug prices influence healthcare spending.

For patients, however, the most important question is often much simpler:

How much will I actually have to pay for my medicine?

Understanding the difference between a manufacturer's list price and a patient's final out-of-pocket cost is therefore essential when discussing drug price increases.

Conclusion

The 2024 analysis highlighted significant changes in prescription drug pricing, with more than 700 medications experiencing price increases, including popular medicines such as Ozempic and Mounjaro.

The average increase was approximately 4.5%, although individual medications experienced substantially different changes.

At the same time, not every medication became more expensive. Several medicines, including certain insulin products, experienced significant price reductions.

The key takeaway is that a manufacturer's list price does not necessarily equal the amount a patient pays.

Insurance coverage, rebates, discounts, formularies, deductibles, and patient assistance programs can all influence the final cost.

As prescription drug prices continue to receive attention from patients, healthcare professionals, policymakers, and pharmaceutical companies, understanding how drug pricing works remains an important part of making informed healthcare decisions.

Pharm Tech Important Link Bank:

Here are a few helpful resources to support your pharmacy technician career:

🔗 Free CEUs for Pharmacy Technicians
https://www.pharmtechsonly.com/resource-center/free-ceus/

🔗 Search Upcoming Conventions in Your Area
https://www.pharmtechsonly.com/resource-center/conventions/

🔗 Rx Study Buddy Kit (Top 200, Math, Law)
https://www.pharmtechsonly.com/store/

🔗 Search Pharmacy Technician Jobs
https://tc.pharmtechsonly.com/careers